Trevi Therapeutics Inc (TRVI)
4.10
+0.10
(+2.50%)
USD |
NASDAQ |
Dec 26, 11:03
Trevi Therapeutics Cash from Investing (Quarterly): 7.667M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aptevo Therapeutics Inc | 0.00 |
| Keros Therapeutics Inc | -0.386M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.556M |
| Cash from Financing (Quarterly) | 4.978M |
| Free Cash Flow | -35.12M |
| Free Cash Flow Per Share (Quarterly) | -0.0944 |
| Free Cash Flow Yield | -8.54% |